Physician profile
Ali Tipu
NPI 1518218304
$8,056.57
in general payments reported to CMS, 2019-2025
35 companies · $3,665 in 2025
The $3,665 reported for 2025 was more than what 85% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.96 · 2021: $126 · 2022: $364 · 2023: $1,240 · 2024: $2,629 · 2025: $3,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,533.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $691.27 | 2023-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $675.43 | 2022-2025 | Korlym |
| Novo Nordisk INC | $672.54 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Xeris Pharmaceuticals, INC. | $653.33 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Lilly USA, LLC | $512.17 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $433.09 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $397.64 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $388.67 | 2022-2025 | |
| Abbott Laboratories | $371.78 | 2023-2025 | Freestyle Libre 3 |
| Amgen INC. | $360.05 | 2022-2025 | Tepezza, Repatha, Evenity |
| Recordati_rare_diseases_inc. | $330.18 | 2024-2025 | Isturisa, Signifor Lar |
| Insulet Corporation | $269.06 | 2023-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.80 | 2022-2025 | Jardiance, Synjardy |
| Chiesi USA, INC. | $178.38 | 2024-2025 | Mycapssa |
| Sequel Med Tech, LLC | $172.87 | 2025 | Twiist |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $163.92 | 2023-2025 | Synthroid |
| Cequr Corporation | $156.21 | 2023-2025 | Cequr Simplicity |
| Beta Bionics, INC. | $150.84 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Mannkind Corporation | $139.30 | 2025 | |
| Medtronic, INC. | $117.65 | 2023-2024 | Minimed 780g |
| Ascendis Pharma Endocrinology INC | $103.22 | 2025 | Yorvipath |
| Radius Health, INC. | $101.50 | 2024-2025 | Tymlos |
| Ibsa Pharma INC. | $100.90 | 2023-2025 | Tirosint, Flector, Licart |
| Novartis Pharmaceuticals Corporation | $91.80 | 2024-2025 | |
| Ascensia Diabetes Care US INC. | $85.23 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $69.48 | 2024-2025 | Strensiq |
| Kyowa Kirin, INC. | $68.52 | 2024 | Crysvita |
| Nevro Corp. | $67.13 | 2023-2024 | Senza |
| Astellas Pharma US INC | $62.18 | 2024-2025 | Veozah |
| Antares Pharma, INC. | $50.79 | 2022-2025 | Xyosted |
| Currax Pharmaceuticals LLC | $48.43 | 2025 | Contrave, Onzetra Xsail |
| Amneal Pharmaceuticals LLC | $40.00 | 2024-2025 | Unithroid |
| Pfizer INC. | $35.25 | 2024-2025 | |
| Amarin Pharma, INC. | $16.79 | 2020 | |
| Janssen Pharmaceuticals, INC | $16.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Tipu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.